A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC).

被引：44

作者：

Hong, Min Hee

Kim, HyeRyun

Park, Seong Yong

Kim, Dae Joon

Lee, Chang Geol

Cho, Jaeho

Kim, Jong Hoon

Kim, Hyeong Ryul

Kim, Yong-Hee

Park, Sook Ryun

Cho, Byoung Chul

机构：

[1] Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South Korea

[2] Yonsei Univ, Coll Med, Dept Thorac & Cardiovascular Surg, Seoul, South Korea

[3] Yonsei Univ, Coll Med, Dept Radiat Oncol, Yonsei Canc Ctr, Seoul, South Korea

[4] Univ Ulsan, Coll Med, Dept Radiat Oncol, Asan Med Ctr, Seoul, South Korea

[5] Univ Ulsan, Coll Med, Dept Thorac & Cardiovasular Surg, Asan Med Ctr, Seoul, South Korea

[6] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea

来源：

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.4027

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4027

引用

页数：1